Elmind Capital »

Dbv Technologies Sa shares owned by Elmind Capital

Quarter-by-quarter ownership of Dbv Technologies Sa (DBVT) shares owned by Elmind Capital from 13F filings

Historical chart of Elmind Capital investment in Dbv Technologies Sa

Tip: Access up to 7 years of quarterly data

All positions including Dbv Technologies Sa held by Elmind Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dbv Technologies Sa by Elmind Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.5M 265k 20.89

More positions owned by Elmind Capital

Cogent Biosciences (COGT)
Syndax Pharmaceuticals (SNDX)
Celldex Therapeutics Com New (CLDX)
Cytomx Therapeutics (CTMX)
Kalvista Pharmaceuticals (KALV)
Cg Oncology (CGON)
Vera Therapeutics Cl A (VERA)
Vaxcyte (PCVX)
Pharvaris N V (PHVS)
Tyra Biosciences (TYRA)
Beam Therapeutics (BEAM)
Miragen Therapeutics (VRDN)
BioCryst Pharmaceuticals (BCRX)
United Therapeutics Corporation (UTHR)
Cullinan Oncology (CGEM)

View all positions for Elmind Capital

Top funds holding Dbv Technologies Sa

MPM Oncology Impact Management
Vivo Capital
Artisan Partners Limited Partnership
Siren
Baker Bros. Advisors
ADAR1 Capital Management
Perceptive Advisors
Patient Square Capital
Octagon Capital Advisors
Ikarian Capital
Redmile Group
Duquesne Family Office
Millennium Management
Atika Capital Management
Elmind Capital

View all funds holding Dbv Technologies Sa